|

Exploring Every Beat Through Sound Technology
Introducing Zargis
Acoustic Cardioscan, the computer-aided heart sound analysis system.
Cardioscan is a computer-assisted medical device designed to support
physicians in analyzing cardiac sounds for the identification and
classification of suspected murmurs. Developed by biomedical
scientists from Siemens and Zargis, the Cardioscan system acquires,
records and analyzes the acoustic signals of the heart and delivers
the results in an easy-to-interpret graphical display.
Cardioscan Supports Detection &
Classification of Suspected Murmurs.
The Cardioscan system
incorporates proprietary heart sound analysis software along with
three very familiar pieces of equipment: an electronic stethoscope,
a laptop computer and a printer. Cardioscan is non-invasive, easy to
use and requires only a few minutes to perform. Through the
stethoscope, the user is easily guided with voice prompts through a
standard, well-accepted auscultation protocol. Cardioscan acquires,
records and analyzes heart sounds, identifying suspected systolic
and diastolic murmurs, S1 and S2 sounds and provides visual
representations of the heart sound characteristics.
When murmurs are detected
by Cardioscan, they are graphically displayed according to their
intensity, timing and location. In addition, Cardioscan indicates
whether or not a suspected murmur meets the characteristics for
classification as Class I murmur according to the ACC/AHA
Recommendations for Echocardiography in Asymptomatic Patients With
Cardiac Murmurs1.
Cardioscan's results are
stored electronically for future reference and may be
printed—allowing physicians to create a baseline report and
providing an additional means with which to compare a patient's
condition over time.
The
interpretations of heart sounds offered by Cardioscan are
significant when used in conjunction with physician over-read that
includes consideration of all other relevant patient clinical data.
11998:
From the American College of Cardiology / American Heart Association
Practice Guidelines for the Management of Patients with Valvular
Heart Disease
|